These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9494967)

  • 1. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is it possible to zero the immune system? Co-stimulatory blockade: experimental studies to achieve transplantation tolerance].
    Aasvang EK; Egfjord M
    Ugeskr Laeger; 2003 Apr; 165(15):1562-5. PubMed ID: 12715660
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation.
    Chatenoud L
    Curr Opin Pharmacol; 2004 Aug; 4(4):403-7. PubMed ID: 15251136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-cell tolerance and autoimmunity].
    Kamradt T; Hansen G; Bechmann I; Burmester GR
    Internist (Berl); 2003 Feb; 44(2):146-52. PubMed ID: 12674734
    [No Abstract]   [Full Text] [Related]  

  • 8. A therapeutic DNA vaccination strategy for autoimmunity and transplantation.
    Li A; Chen J; Hattori M; Franco E; Zuppan C; Ojogho O; Iwaki Y; Escher A
    Vaccine; 2010 Feb; 28(8):1897-904. PubMed ID: 20188244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies and fusion proteins in medicine.
    Liossis SN; Tsokos GC
    J Allergy Clin Immunol; 2005 Oct; 116(4):721-9; quiz 730. PubMed ID: 16210042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory T cells - a possible promising target in the treatment of autoimmune diseases].
    Enghard P; Riemekasten G
    Z Rheumatol; 2003 Aug; 62(4):355-60. PubMed ID: 12928939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
    Kohm AP; Turley DM; Miller SD
    Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.
    Chatenoud L
    Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of costimulatory molecules in autoimmunity.
    Kobata T; Azuma M; Yagita H; Okumura K
    Rev Immunogenet; 2000; 2(1):74-80. PubMed ID: 11324695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
    Win TS; Pettigrew GJ
    Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
    Pescovitz MD
    Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs in autoimmune diseases.
    Herrmann DB; Bicker U
    Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.